|
HS Code |
197644 |
| Product Name | Cytidine Sulfate |
| Cas Number | 6082-33-7 |
| Molecular Formula | C9H15N3O9S |
| Molecular Weight | 357.30 g/mol |
| Appearance | White to off-white powder |
| Solubility | Soluble in water |
| Ph 1 Solution | 5.0 - 7.0 |
| Storage Conditions | Store at 2-8°C, protect from light and moisture |
| Synonyms | Cytidine sulfuric acid salt |
| Purity | ≥98% |
| Chemical Structure | Nucleoside sulfate (cytidine backbone) |
| Application | Biochemical research, nucleotide synthesis |
| Shelf Life | 2 years (under recommended storage) |
As an accredited Cytidine Sulfate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Cytidine Sulfate, 5 grams, packaged in a sealed amber glass bottle with tamper-evident cap, labeled for laboratory use. |
| Shipping | Cytidine Sulfate is shipped in tightly sealed, chemical-resistant containers to prevent moisture and contamination. The packaging ensures safe transport, complying with relevant chemical safety regulations. It should be stored and shipped at controlled room temperature, away from incompatible substances. Proper labeling and documentation accompany the shipment to ensure regulatory compliance. |
| Storage | Cytidine sulfate should be stored in a tightly closed container, protected from light, moisture, and air. Keep it at room temperature, ideally between 15–25°C (59–77°F), in a dry, well-ventilated area away from incompatible substances. For long-term storage, refrigeration may be recommended. Always follow safety guidelines and consult the Material Safety Data Sheet (MSDS) for detailed handling and storage procedures. |
Applications of Cytidine Sulfate in Industrial ManufacturingCytidine sulfate serves as a critical intermediate in various advanced industrial sectors. As a chemical manufacturer, we supply cytidine sulfate to companies handling rigorous formulation, strict quality control, and demanding end-product performance in downstream specialty production. Below we outline real-world industrial application areas, emphasizing regulatory framework, precise usage ratios, specific process integration points, and the legitimate final goods produced. 1. Pharmaceutical Nucleoside Intermediate ProductionPharmaceutical manufacturers employ cytidine sulfate as a key nucleoside starting material for synthesizing diverse cytidine-based active pharmaceutical ingredients (APIs), especially in the antiviral, anticancer, and central nervous system drug sectors. Downstream API producers integrate cytidine sulfate during multi-step organic synthesis to yield high-purity cytidine analogues, often using GMP-compliant closed-process reactors and validated purification systems. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Biotechnology Fermentation Media ManufacturingIn biotechnological fermentation, producers use cytidine sulfate as a nucleotide precursor for advanced microbial and mammalian cell culture media. It enhances nucleic acid biosynthesis in engineered strains for diagnostic reagent, vaccine, and enzyme production. Media compounders incorporate cytidine sulfate at tightly controlled concentrations to balance cell growth with metabolite expression. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Nutraceutical Nucleotide Supplement ManufacturingNutraceutical companies formulate cytidine sulfate into dietary supplements as a bioavailable source of cytidine for cognitive and neurological support products. Manufacturers apply food-grade GMP controls to ensure safety, quality, and traceability. They blend cytidine sulfate directly with vitamins, minerals, and carrier excipients, then process using validated encapsulation or tableting lines for human dietary intake. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. RNA Synthesis Reagent ProductionHigh-purity cytidine sulfate supports DNA/RNA synthesis companies in reagent manufacturing for molecular biology, diagnostics, and gene therapy sectors. Downstream users convert the compound into nucleotide triphosphates (NTPs) required in enzymatic RNA synthesis and in vitro transcription kits. Stringent quality management ensures low endotoxin and nucleic acid impurity levels. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Veterinary Injectable Formulation ManufacturingManufacturers of veterinary pharmaceutical products employ cytidine sulfate as a precursor for cytidine-based injectable solutions used in animal neurological and metabolic therapies. Production adheres to veterinary GMP guidelines, with the substance solubilized, filtered, and batch-sterilized before aseptic filling. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Cytidine Sulfate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Our production lines have specialized in nucleotide chemistry for over twenty years. Cytidine sulfate has grown along with us, from a modest research target into one of our staple offerings. Through customer trials, we’ve seen its value up-close across multiple industries, with researchers and formulation teams regularly sending us feedback on what works and where challenges pop up. Each kilogram of cytidine sulfate leaving our facility reflects more than consistency; it carries years of troubleshooting, conversation, and steady improvements in synthesis and purification.
Our principal cytidine sulfate product follows our in-house specification: fine white to off-white crystalline powder, batch-tested to maintain purity over 99%. This model, cataloged internally as CYT-SUL-210, meets standard requirements across both research and industrial processing. Each lot undergoes HPLC and NMR analysis. Water content, residual solvents, inorganic ions—these are not afterthoughts, but regularly monitored features because downstream specialists have told us, unprompted, how trace contaminants disrupt their work. We never assign generic grades to nucleotide products: everything is documented and tied to an actual batch, with full traceability back to source materials.
In real-world scenarios, purity matters much more than catalog numbers or paperwork suggest. One year, a pharmaceutical client flagged impurities that stemmed from sub-par raw cytidine purchased on the open market. Critical reactions yielded inconsistent results, and their chromatography became a headache. Our own approach addresses these variables at the earliest stage. Instead of outsourcing synthesis, we handle cytidine streams from the very beginning—using only tightly-qualified cytosine lots, followed by full neutralization steps. Each filtration pass is monitored for sulfate carry-over and for byproduct build-up like uridine or deaminated cytidines.
Standard HPLC comparison (against USP and in-house reference standards) forms part of every certificate. Heavy metals analysis is performed on a rotating lot schedule. While some would cut corners, our approach values minimal batch-to-batch fluctuation, even when scaling up to ton quantities. That’s a lesson learned by sticking with our product through its life cycle and by listening when clients call with a problem at 9pm.
End users report many uses of cytidine sulfate, far beyond the concept of “raw material.” Some use it as a nucleotide precursor, running it through phosphorylation to produce active pharmaceutical intermediates for antiviral and anticancer agents, especially in emerging nucleoside analogs. Biotechnological companies introduce cytidine sulfate into fermentation media as a supplement when yeast or bacterial cultures are engineered to overproduce cytidine-derived medicines. In our observation, compared with free base cytidine, the sulfate behaves with greater solubility and less degradation over time—attributes critical for fermentation scale-up.
A different sector of demand comes from diagnostic and molecular biology labs. Enzymatic reactions relying on nucleotides have shown sensitivity to both pH and salt content. Because cytidine sulfate dissolves cleanly in aqueous buffers, researchers can easily adjust their recipe without worrying about unpredictable shifts in osmolarity or risk of compounding with incompatible cations.
We’ve also responded to inquiries from food additive companies and cosmetic formulators exploring cytidine derivatives for newer ingredient applications. Here, documentation and traceability matters. Our certificates are tailored for full ingredient transparency, as required for import/export registration and product dossiers, especially in East Asia and South America.
Every chemist has wrestled with a “same, but different” scenario when sourcing cytidine compounds. One supplier’s cytidine hydrochloride will not match another’s purely by theoretical equivalence. Our experience—confirmed by countless technical discussions—shows well-documented differences between cytidine sulfate, cytidine free base, and monophosphates. Sulfate salt provides greater thermal and hydrolytic stability compared to the free base, crucial for long-term storage or international shipping. Monophosphate forms, while attractive for some nucleotide syntheses, are more hygroscopic and prone to clumping unless packaged in custom moisture-barrier containers.
We have worked with manufacturers who initially tried to substitute sulfate salt in phosphate or hydrochloride workflows, only to find that sulfate is less likely to interfere with certain in vitro reactions and does not introduce problematic cation exchange in resin columns. Routine feedback: cytidine sulfate stands out for buffering capacity and straightforward dissolution, saving both time and material waste.
From a regulatory perspective, sulfate anion usually presents far fewer issues than chloride or phosphate when customers perform heavy metal analysis or check for genotoxic risk. This difference comes into sharp focus in markets tightly scrutinizing residual solvents and ion profiles.
Our shopfloor teams hear from customers requesting modified grades—larger crystalline forms for slower dissolution, micronized powder for rapid dispersion, different bulk density for equipment compatibility. Most chemical plants are set up for fixed processes. We maintain flexibility in our milling and sieving lines, with batch notes that reflect every change implemented at the customer’s suggestion.
We can recount cases where end-users asked about introducing antioxidants into the packaging, or about switching drum liners to avoid static charge during powder transfer. These might look like small issues to outsiders, but they matter if you have direct experience at the bench. Unsolicited feedback from a fermentation plant manager in Korea once resulted in an entire packaging audit, leading us to change lining materials company-wide. That’s one reason formulation chemists and plant technicians still call us by phone, years after their project ends.
Within the chemical industry, supply chain risk dominates conversation, especially for niche API precursors. We build in-house capacity not just to ensure uninterrupted production, but to control every aspect of raw material sourcing. Every incoming lot of cytosine and sulfuric acid meets pre-agreed standards set between purchasing and lab teams, reducing the chance of off-batch cytidine sulfate ever leaving our facility.
We have invested in closed-loop waste handling to minimize sulfate emissions, and solid byproducts head into licensed treatment channels rather than the general waste stream. Our quality lab monitors each loading into drums or bags, and batch numbers are logged against both in-plant QA and customer release documents. We don’t chase “just-in-time” inventory when it comes to cytidine derivatives; stock is maintained in temperature-controlled spaces, with routine retesting to confirm conformity long after initial batch release.
Sustainability pressures from regulators and customers shape our daily operations. Incremental improvements—reducing solvent use, implementing solvent recovery, switching to local supply chains where possible—have quietly built resilience. In drought-prone regions, we re-use cooling water and cap our wastewater output. These improvements keep costs predictable for our users, lowering the likelihood of sudden supply shocks.
Nucleotide chemistry is less forgiving than it looks from the outside. Contaminant carry-through and even shelf storage can impact the performance in high-stakes clinical or research settings. Biological reactions behave unpredictably if a single batch strays from spec. Our philosophy has been to work with data, not assumptions. Each time a partner finds something unexpected—a chromatic impurity, non-conforming melting point, inconsistent crystallinity—they reach out, expecting not just a replacement batch but an explanation. That drives our detailed lot-history and event logging.
Regulatory demands continue to escalate, especially for cytidine derivatives imported into the European Union, Japan, and North America. Documentation now focuses on full origin traceability, detailed impurity profiling, and proof of compliance with chemical hazard and safety norms. We handle these not as paperwork burdens but as opportunities to share what we know: everything from process mass balance to spill response. In a highly scrutinized supply environment, trust grows by demonstrating tangible controls on every variable.
Something remarkable happens when our production chemists meet researchers in person. We learn as much as we teach. In recent years, customers from RNA-based therapeutic companies have laid out new requirements for purity, storage, and analytical support. Their processes depend not just on receiving the right powder, but on getting shipping data, precise labeling, and real-time access to QC managers during project critical-path phases. Speed matters, so we run overnight analysis for urgent custom batches.
Batch-to-batch repeatability is a make-or-break metric, discovered the hard way by a partner scaling from 5-gram to 10-kilogram lots. Their feedback—dissolution quirks, pH drift, storage observations—feeds straight back into future lot sheets. Now, most final products ship with attached analytical chromatograms, impurity tables, and batch-specific stability data, not generic summaries pulled from old spec sheets.
The requests coming in from R&D teams drive us to keep investing in staff training and equipment upgrades. One project in 2022 led us to install a dedicated ion chromatography line to resolve trace sulfate and phosphate contamination. This paid dividends when another client flagged cross-contaminant risk in their diagnostic kit—evidence that analytical upgrades don’t live in isolation, but reverberate throughout the customer community.
Bulk cytidine sulfate packaging often hides subtle problems: dusting on opening, clumping in transit during rainy seasons, loss of batch identity in poorly managed supply chains. We learned over time what actually matters—double-lined PE bags with high-barrier outer drums for large lots, pharmaceutical-grade vials for small research quantities. Each package receives an external and internal lot number. For high-value projects, we offer tamper-evident bands or shock indicators by request.
Our logistics partners have learned that temperature excursions and condensation can cause real headaches. By tracking climate data, we adjust insulated packaging for trans-Pacific shipments during typhoon season, and add humidity absorbers for tropical routes. Customers receiving cytidine sulfate for regulated APIs often require full temperature and event logs for customs clearances, so our documentation accompanies each batch—not as an afterthought, but as standard procedure honed by years of real problems and fixes.
Demand from RNA therapy platforms continues to climb, and clinical research asks for even purer material with reduced trace nucleoside contamination. Automation on the lab floor pushes our product team to tighten particle size range and minimize dusting, especially for dispensing robots. In food and cosmetic applications, our clients advocate for non-GMO confirmation, allergen declarations, and extended shelf-life data. We follow the regulatory discussion in all these spaces—and our commercial staff works with technical staff to make sure incoming requests reach the right chemist or engineer.
A few years ago, we started working with an agricultural tech company exploring cytidine derivatives in microbially enhanced plant growth media. Now, we collaborate on new product forms, each serving a narrow, real-world requirement rather than chasing “one size fits all.” We’re increasingly contacted for application-driven modifications—coating agents for tableting, ultra-low-metal cytidine sulfate for advanced PCR kits, and custom-packaged lots for field research. Everything ties back to our workshop mentality: put people with experience on the problem, talk directly to the users, and don’t shy away from awkward technical conversations.
Trust grows on the shop floor and in the laboratory, not just from brochures or certificates. Cytidine sulfate is more than a chemical—it's a product that reveals how much care, honest mistakes, and hard-won lessons go into manufacturing when you work with customers instead of just shipping boxes. Every improvement, from crystallization tweak to packaging change, finds its way back to the product line through real-world feedback. We keep daily logs because over the years, those notes have kept projects running and customers happy through everything from regulatory audits to sudden surges in demand.
Experience proves that supplying cytidine sulfate goes far beyond ticking specification boxes. It requires hands-on problem-solving, attention to detail, and the willingness to engage in open-ended technical dialogue. From batch history to real-time troubleshooting, we keep our ears open and solutions grounded in actual practice. Our perspective is shaped by what works, what stumbles, and what fixes last in the field, not just on paper.